11/05/2024 | Press release | Distributed by Public on 11/05/2024 12:10
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Class A |
$
64
|
1.21
%
|
Fund net assets |
$
941,866,915
|
Total number of portfolio holdings | 120 |
Portfolio turnover
for
the reporting period
|
23% |
AstraZeneca PLC, ADR |
2.7
%
|
Shell PLC |
2.4
%
|
Sanofi SA |
2.4
%
|
Novo Nordisk A/S, Class B |
2.2
%
|
Check Point Software Technologies Ltd. |
2.1
%
|
Mitsubishi UFJ Financial Group, Inc. |
2.1
%
|
ITOCHU Corp. |
2.0
%
|
Northern Star Resources Ltd. |
2.0
%
|
TOPPAN Holdings, Inc. |
2.0
%
|
ASR Nederland NV |
1.9
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Advisor Class |
$
51
|
0.96
%
|
Fund net
assets
|
$
941,866,915
|
Total number of portfolio holdings | 120 |
Portfolio turnover for the reporting period | 23% |
AstraZeneca PLC, ADR |
2.7
%
|
Shell PLC |
2.4
%
|
Sanofi SA |
2.4
%
|
Novo Nordisk A/S, Class B |
2.2
%
|
Check Point Software Technologies Ltd. |
2.1
%
|
Mitsubishi UFJ Financial Group, Inc. |
2.1
%
|
ITOCHU Corp. |
2.0
%
|
Northern Star Resources Ltd. |
2.0
%
|
TOPPAN Holdings, Inc. |
2.0
%
|
ASR Nederland NV |
1.9
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Institutional Class |
$
51
|
0.96
%
|
Fund net assets |
$
941,866,915
|
Total number of portfolio holdings | 120 |
Portfolio turnover for the reporting period | 23% |
AstraZeneca PLC, ADR |
2.7
%
|
Shell PLC |
2.4
%
|
Sanofi SA |
2.4
%
|
Novo Nordisk A/S,
Class
B
|
2.2
%
|
Check Point Software Technologies Ltd. |
2.1
%
|
Mitsubishi UFJ Financial Group, Inc. |
2.1
%
|
ITOCHU Corp. |
2.0
%
|
Northern Star Resources Ltd. |
2.0
%
|
TOPPAN Holdings, Inc. |
2.0
%
|
ASR Nederland NV |
1.9
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Institutional 2 Class |
$
48
|
0.90
%
|
Fund net assets |
$
941,866,915
|
Total number of portfolio holdings | 120 |
Portfolio turnover for the reporting period | 23% |
AstraZeneca PLC, ADR |
2.7
%
|
Shell PLC |
2.4
%
|
Sanofi SA |
2.4
%
|
Novo Nordisk A/S, Class B |
2.2
%
|
Check Point Software Technologies Ltd. |
2.1
%
|
Mitsubishi UFJ Financial Group, Inc. |
2.1
%
|
ITOCHU Corp. |
2.0
%
|
Northern Star Resources Ltd. |
2.0
%
|
TOPPAN Holdings, Inc. |
2.0
%
|
ASR Nederland NV |
1.9
%
|
Class | Cost of a $10,000 investment |
Cost paid as a percentage of a $10,000
investment
|
Institutional 3 Class |
$
44
|
0.83
%
|
Fund net assets |
$
941,866,915
|
Total number of portfolio holdings | 120 |
Portfolio turnover for the reporting period | 23% |
AstraZeneca PLC, ADR |
2.7
%
|
Shell PLC |
2.4
%
|
Sanofi SA |
2.4
%
|
Novo Nordisk A/S, Class B |
2.2
%
|
Check Point Software Technologies Ltd. |
2.1
%
|
Mitsubishi UFJ Financial Group, Inc. |
2.1
%
|
ITOCHU Corp. |
2.0
%
|
Northern Star Resources Ltd. |
2.0
%
|
TOPPAN Holdings, Inc. |
2.0
%
|
ASR Nederland NV |
1.9
%
|
Class | Cost of a $10,000 investment | Cost paid as a percentage of a $10,000 investment |
Class R |
$
77
|
1.46
%
|
Fund net assets |
$
941,866,915
|
Total number of portfolio holdings | 120 |
Portfolio turnover for the reporting period | 23% |
AstraZeneca PLC, ADR |
2.7
%
|
Shell PLC |
2.4
%
|
Sanofi SA |
2.4
%
|
Novo Nordisk A/S, Class B |
2.2
%
|
Check Point Software Technologies Ltd. |
2.1
%
|
Mitsubishi UFJ Financial Group, Inc. |
2.1
%
|
ITOCHU Corp. |
2.0
%
|
Northern Star Resources Ltd. |
2.0
%
|
TOPPAN Holdings, Inc. |
2.0
%
|
ASR Nederland NV |
1.9
%
|
Item 2. Code of Ethics.
Not applicable.
Item 3. Audit Committee Financial Expert.
Not applicable.
Item 4. Principal Accountant Fees and Services.
Not applicable.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) The registrant's "Schedule I - Investments in securities of unaffiliated issuers" (as set forth in 17 CFR 210.12-12) is included in Item 7 of this Form N-CSR.
(b) Not applicable.
Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.
Not FDIC or NCUA Insured
|
No Financial Institution Guarantee
|
May Lose Value
|
Portfolio of Investments
|
3
|
Statement of Assets and Liabilities
|
9
|
Statement of Operations
|
11
|
Statement of Changes in Net Assets
|
12
|
Financial Highlights
|
14
|
Notes to Financial Statements
|
18
|
Approval of Management Agreement
|
31
|
Common Stocks 97.2%
|
||
Issuer
|
Shares
|
Value ($)
|
Australia 4.0%
|
||
Northern Star Resources Ltd.
|
1,831,922
|
18,705,163
|
Paladin Energy Ltd.(a)
|
892,434
|
5,918,093
|
Santos Ltd.
|
2,701,973
|
13,173,126
|
Total
|
37,796,382
|
|
Austria 0.4%
|
||
Kontron AG
|
199,727
|
3,755,190
|
Belgium 1.3%
|
||
Liberty Global Ltd., Class C(a)
|
605,086
|
11,902,042
|
Brazil 0.5%
|
||
JBS S/A
|
810,036
|
5,000,249
|
Canada 4.9%
|
||
Cameco Corp.
|
236,646
|
9,664,623
|
Celestica, Inc.(a)
|
145,518
|
7,409,777
|
Energy Fuels, Inc.(a)
|
645,016
|
3,160,578
|
Nutrien Ltd.
|
83,608
|
4,048,299
|
Pan American Silver Corp.
|
254,686
|
5,147,204
|
Vermilion Energy, Inc.
|
319,600
|
3,285,488
|
Whitecap Resources, Inc.
|
1,785,158
|
13,590,859
|
Total
|
46,306,828
|
|
Denmark 2.2%
|
||
Novo Nordisk A/S, Class B
|
150,158
|
20,858,473
|
Finland 1.8%
|
||
UPM-Kymmene OYJ
|
489,571
|
16,501,895
|
France 10.0%
|
||
AXA SA
|
353,215
|
13,443,057
|
Cie de Saint-Gobain SA
|
140,406
|
12,269,502
|
Cie Generale des Etablissements Michelin SCA
|
210,850
|
8,278,905
|
Eiffage SA
|
131,456
|
13,798,308
|
Sanofi SA
|
199,098
|
22,346,384
|
Societe Generale SA
|
364,445
|
8,809,710
|
Sodexo SA
|
61,835
|
5,502,369
|
TotalEnergies SE
|
134,382
|
9,244,383
|
Total
|
93,692,618
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Germany 3.1%
|
||
Duerr AG
|
149,044
|
3,270,123
|
E.ON SE
|
575,188
|
8,153,959
|
Fresenius Medical Care AG
|
152,740
|
5,896,277
|
KION Group AG
|
173,583
|
6,760,392
|
TeamViewer SE(a)
|
336,674
|
4,658,496
|
Total
|
28,739,247
|
|
Greece 1.0%
|
||
JUMBO SA
|
354,329
|
8,961,530
|
Hong Kong 0.6%
|
||
WH Group Ltd.
|
7,187,902
|
5,213,178
|
Indonesia 1.1%
|
||
PT Bank Rakyat Indonesia Persero Tbk
|
32,353,600
|
10,772,328
|
Ireland 2.2%
|
||
Bank of Ireland Group PLC
|
842,927
|
9,683,144
|
Flutter Entertainment PLC(a)
|
52,961
|
11,313,075
|
Total
|
20,996,219
|
|
Israel 2.9%
|
||
Bank Hapoalim BM
|
778,178
|
7,757,780
|
Check Point Software Technologies Ltd.(a)
|
102,622
|
19,754,735
|
Total
|
27,512,515
|
|
Italy 0.7%
|
||
Buzzi Unicem SpA
|
174,406
|
6,853,927
|
Japan 24.6%
|
||
Amano Corp.
|
236,800
|
7,136,820
|
BayCurrent, Inc.
|
175,500
|
5,594,892
|
Hitachi Ltd.
|
340,700
|
8,405,078
|
ITOCHU Corp.
|
355,700
|
18,938,949
|
JustSystems Corp.
|
95,400
|
2,271,440
|
Kakaku.com, Inc.
|
312,300
|
5,369,760
|
Kinden Corp.
|
284,900
|
6,131,986
|
Komatsu Ltd.
|
408,400
|
11,428,028
|
Macnica Holdings, Inc.
|
278,300
|
11,365,812
|
MatsukiyoCocokara & Co.
|
810,400
|
13,115,973
|
Mitsubishi UFJ Financial Group, Inc.
|
1,865,800
|
19,684,612
|
Otsuka Corp.
|
659,400
|
15,687,302
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
PAL GROUP Holdings Co., Ltd.
|
322,900
|
5,206,619
|
Sankyo Co., Ltd.
|
1,202,800
|
17,336,730
|
Sanwa Holdings Corp.
|
341,900
|
7,842,427
|
Shimamura Co., Ltd.
|
202,000
|
10,785,776
|
Ship Healthcare Holdings, Inc.
|
445,700
|
6,706,956
|
Sumitomo Corp.
|
199,700
|
4,748,546
|
Suntory Beverage & Food Ltd.
|
175,800
|
6,464,760
|
Suzuken Co., Ltd.
|
251,900
|
8,927,199
|
Takuma Co., Ltd.
|
215,400
|
2,404,067
|
TBS Holdings, Inc.
|
280,300
|
7,812,400
|
TOPPAN Holdings, Inc.
|
608,300
|
18,366,243
|
USS Co., Ltd.
|
1,055,900
|
9,695,503
|
Total
|
231,427,878
|
|
Jersey 0.2%
|
||
Arcadium Lithium PLC(a),(b)
|
839,149
|
2,274,094
|
Netherlands 11.4%
|
||
Adyen NV(a)
|
5,054
|
7,458,712
|
ASR Nederland NV
|
356,490
|
17,470,866
|
Heineken NV
|
100,932
|
9,106,505
|
ING Groep NV
|
919,634
|
16,720,912
|
Koninklijke Ahold Delhaize NV
|
478,869
|
16,441,356
|
Prosus NV, Class N
|
468,405
|
17,362,638
|
Shell PLC
|
635,288
|
22,510,517
|
Total
|
107,071,506
|
|
Norway 0.6%
|
||
SalMar ASA
|
117,144
|
6,082,350
|
Russian Federation -%
|
||
Lukoil PJSC(c),(d),(e),(f)
|
33,398
|
-
|
Singapore 2.8%
|
||
DBS Group Holdings Ltd.
|
612,670
|
17,108,382
|
Venture Corp., Ltd.
|
880,200
|
9,460,193
|
Total
|
26,568,575
|
|
South Africa 0.1%
|
||
Impala Platinum Holdings Ltd.
|
314,962
|
1,356,470
|
South Korea 1.9%
|
||
Samsung Electronics Co., Ltd.
|
226,095
|
12,556,937
|
Youngone Corp.
|
175,398
|
4,993,655
|
Total
|
17,550,592
|
Common Stocks (continued)
|
||
Issuer
|
Shares
|
Value ($)
|
Sweden 0.8%
|
||
SKF AB, Class B
|
411,331
|
7,794,177
|
Switzerland 3.5%
|
||
Landis+Gyr Group AG(a)
|
101,344
|
9,135,746
|
Nestlé SA, Registered Shares
|
68,053
|
7,298,014
|
Novartis AG, Registered Shares
|
42,263
|
5,106,138
|
Roche Holding AG, Genusschein Shares
|
34,371
|
11,635,298
|
Total
|
33,175,196
|
|
Taiwan 2.2%
|
||
Parade Technologies Ltd.
|
413,000
|
10,412,770
|
Taiwan Semiconductor Manufacturing Co., Ltd.
|
356,000
|
10,539,513
|
Total
|
20,952,283
|
|
United Kingdom 9.3%
|
||
AstraZeneca PLC, ADR(b)
|
289,991
|
25,409,012
|
DCC PLC
|
193,769
|
13,690,623
|
JD Sports Fashion PLC
|
7,803,647
|
14,224,088
|
Just Group PLC
|
2,581,448
|
4,844,964
|
TP Icap Group PLC
|
3,787,440
|
12,086,929
|
Vodafone Group PLC
|
12,045,807
|
11,807,377
|
WPP PLC
|
536,402
|
5,138,167
|
Total
|
87,201,160
|
|
United States 3.1%
|
||
ACADIA Pharmaceuticals, Inc.(a)
|
23,092
|
382,865
|
Burford Capital Ltd.
|
737,947
|
9,969,664
|
Insmed, Inc.(a)
|
26,574
|
2,032,114
|
Jazz Pharmaceuticals PLC(a)
|
82,816
|
9,605,000
|
Primo Water Corp.
|
327,393
|
7,235,385
|
Total
|
29,225,028
|
|
Total Common Stocks
(Cost $780,770,141)
|
915,541,930
|
|
|
||
Exchange-Traded Equity Funds 1.8%
|
||
|
Shares
|
Value ($)
|
United States 1.8%
|
||
iShares MSCI EAFE ETF
|
199,564
|
16,559,820
|
Total Exchange-Traded Equity Funds
(Cost $15,440,204)
|
16,559,820
|
|
|
Money Market Funds 0.2%
|
||
|
Shares
|
Value ($)
|
Columbia Short-Term Cash Fund, 5.521%(g),(h)
|
2,022,544
|
2,022,140
|
Total Money Market Funds
(Cost $2,021,937)
|
2,022,140
|
|
Total Investments in Securities
(Cost $798,232,282)
|
934,123,890
|
|
Other Assets & Liabilities, Net
|
7,743,025
|
|
Net Assets
|
$941,866,915
|
Forward foreign currency exchange contracts
|
|||||
Currency to
be sold
|
Currency to
be purchased
|
Counterparty
|
Settlement
date
|
Unrealized
appreciation ($)
|
Unrealized
depreciation ($)
|
45,614,000 CAD
|
33,296,227 USD
|
Barclays
|
10/08/2024
|
-
|
(587,468
)
|
8,091,706 USD
|
54,654,000 DKK
|
Barclays
|
10/08/2024
|
23,350
|
-
|
31,477,643 USD
|
47,626,000 AUD
|
Citi
|
10/08/2024
|
785,035
|
-
|
25,183,946 USD
|
19,621,000 GBP
|
Goldman Sachs International
|
10/08/2024
|
592,123
|
-
|
16,767,000 ILS
|
4,541,220 USD
|
HSBC
|
10/08/2024
|
-
|
(75,818
)
|
35,442,000 SGD
|
26,975,887 USD
|
HSBC
|
10/08/2024
|
-
|
(239,145
)
|
21,589,296 USD
|
18,556,000 CHF
|
HSBC
|
10/08/2024
|
328,536
|
-
|
2,457,000 SGD
|
1,892,119 USD
|
JPMorgan
|
10/08/2024
|
5,450
|
-
|
2,841,287 USD
|
2,142,000 GBP
|
JPMorgan
|
10/08/2024
|
-
|
(27,346
)
|
4,596,091,000 JPY
|
31,454,270 USD
|
Morgan Stanley
|
10/08/2024
|
-
|
(141,751
)
|
15,806,063,000 KRW
|
11,685,689 USD
|
Morgan Stanley
|
10/08/2024
|
-
|
(157,083
)
|
1,062,923,000 TWD
|
33,138,675 USD
|
Morgan Stanley
|
10/08/2024
|
-
|
(234,353
)
|
4,739,625 USD
|
6,968,000 AUD
|
Morgan Stanley
|
10/08/2024
|
-
|
(19,381
)
|
1,893,725 USD
|
1,586,000 CHF
|
Morgan Stanley
|
10/08/2024
|
-
|
(20,386
)
|
7,572,483 USD
|
6,754,000 EUR
|
Morgan Stanley
|
10/08/2024
|
-
|
(94,869
)
|
6,284,637 USD
|
67,236,000 NOK
|
Morgan Stanley
|
10/08/2024
|
59,534
|
-
|
36,851,003 USD
|
33,388,000 EUR
|
State Street
|
10/08/2024
|
114,142
|
-
|
5,082,000 CAD
|
3,783,449 USD
|
UBS
|
10/08/2024
|
8,359
|
-
|
5,381,723 USD
|
56,186,000 SEK
|
UBS
|
10/08/2024
|
100,110
|
-
|
271,112,000 JPY
|
1,893,581 USD
|
Wells Fargo
|
10/08/2024
|
29,810
|
-
|
49,609,000 NOK
|
4,745,570 USD
|
Wells Fargo
|
10/08/2024
|
64,625
|
-
|
15,279,037 USD
|
25,464,000 NZD
|
Wells Fargo
|
10/08/2024
|
641,549
|
-
|
Total
|
|
|
2,752,623
|
(1,597,600
)
|
Call option contracts written
|
||||||||
Description
|
Counterparty
|
Trading
currency
|
Notional
amount
|
Number of
contracts
|
Exercise
price/Rate
|
Expiration
date
|
Premium
received ($)
|
Value ($)
|
Arcadium Lithium PLC
|
Morgan Stanley
|
USD
|
(2,273,961
)
|
(8,391
)
|
3.00
|
9/20/2024
|
(29,141
)
|
(62,932
)
|
AstraZeneca PLC
|
Morgan Stanley
|
USD
|
(8,779,524
)
|
(1,002
)
|
90.00
|
9/20/2024
|
(48,699
)
|
(63,126
)
|
Total
|
|
|
(77,840
)
|
(126,058
)
|
(a)
|
Non-income producing investment.
|
(b)
|
This security or a portion of this security has been pledged as collateral in connection with derivative contracts.
|
(c)
|
Represents fair value as determined in good faith under procedures approved by the Board of Trustees. At August 31, 2024, the total value of these securities amounted to $0, which represents less than 0.01% of total net assets.
|
(d)
|
Denotes a restricted security, which is subject to legal or contractual restrictions on resale under federal securities laws. Disposal of a restricted investment may involve time-consuming negotiations and expenses, and prompt sale at an acceptable price may be difficult to achieve. Private placement securities are generally considered to be restricted, although certain of those securities may be traded between qualified institutional investors under the provisions of Section 4(a)(2) and Rule 144A. The Fund will not incur any registration costs upon such a trade. These securities are valued at fair value determined in good faith under consistently applied procedures approved by the Fund's Board of Trustees. At August 31, 2024, the total market value of these securities amounted to $0, which represents less than 0.01% of total net assets. Additional information on these securities is as follows:
|
Security
|
Acquisition
Dates
|
Shares
|
Cost ($)
|
Value ($)
|
Lukoil PJSC
|
01/25/2022-02/02/2022
|
33,398
|
2,752,771
|
-
|
(e)
|
As a result of sanctions and restricted cross-border payments, certain income and/or principal has not been recognized by the Fund. The Fund will continue to monitor the net realizable value and record the income when it is considered collectible.
|
(f)
|
Valuation based on significant unobservable inputs.
|
(g)
|
The rate shown is the seven-day current annualized yield at August 31, 2024.
|
(h)
|
As defined in the Investment Company Act of 1940, as amended, an affiliated company is one in which the Fund owns 5% or more of the company's outstanding voting securities, or a company which is under common ownership or control with the Fund. The value of the holdings and transactions in these affiliated companies during the period ended August 31, 2024 are as follows:
|
Affiliated issuers
|
Beginning
of period($)
|
Purchases($)
|
Sales($)
|
Net change in
unrealized
appreciation
(depreciation)($)
|
End of
period($)
|
Realized gain
(loss)($)
|
Dividends($)
|
End of
period shares
|
Columbia Short-Term Cash Fund, 5.521%
|
||||||||
|
4,086,345
|
97,014,267
|
(99,078,674
)
|
202
|
2,022,140
|
(346
)
|
135,047
|
2,022,544
|
ADR
|
American Depositary Receipt
|
AUD
|
Australian Dollar
|
CAD
|
Canada Dollar
|
CHF
|
Swiss Franc
|
DKK
|
Danish Krone
|
EUR
|
Euro
|
GBP
|
British Pound
|
ILS
|
Israeli Shekel
|
JPY
|
Japanese Yen
|
KRW
|
South Korean Won
|
NOK
|
Norwegian Krone
|
NZD
|
New Zealand Dollar
|
SEK
|
Swedish Krona
|
SGD
|
Singapore Dollar
|
TWD
|
New Taiwan Dollar
|
USD
|
US Dollar
|
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Total ($)
|
Investments in Securities
|
||||
Common Stocks
|
||||
Australia
|
-
|
37,796,382
|
-
|
37,796,382
|
Austria
|
-
|
3,755,190
|
-
|
3,755,190
|
Belgium
|
11,902,042
|
-
|
-
|
11,902,042
|
Brazil
|
5,000,249
|
-
|
-
|
5,000,249
|
Canada
|
46,306,828
|
-
|
-
|
46,306,828
|
Denmark
|
-
|
20,858,473
|
-
|
20,858,473
|
Finland
|
-
|
16,501,895
|
-
|
16,501,895
|
France
|
-
|
93,692,618
|
-
|
93,692,618
|
Germany
|
-
|
28,739,247
|
-
|
28,739,247
|
Greece
|
-
|
8,961,530
|
-
|
8,961,530
|
Hong Kong
|
-
|
5,213,178
|
-
|
5,213,178
|
Indonesia
|
-
|
10,772,328
|
-
|
10,772,328
|
Ireland
|
-
|
20,996,219
|
-
|
20,996,219
|
Israel
|
19,754,735
|
7,757,780
|
-
|
27,512,515
|
Italy
|
-
|
6,853,927
|
-
|
6,853,927
|
Japan
|
-
|
231,427,878
|
-
|
231,427,878
|
Jersey
|
2,274,094
|
-
|
-
|
2,274,094
|
Netherlands
|
-
|
107,071,506
|
-
|
107,071,506
|
Norway
|
-
|
6,082,350
|
-
|
6,082,350
|
Russian Federation
|
-
|
-
|
0
*
|
0
*
|
Singapore
|
-
|
26,568,575
|
-
|
26,568,575
|
South Africa
|
-
|
1,356,470
|
-
|
1,356,470
|
South Korea
|
-
|
17,550,592
|
-
|
17,550,592
|
Sweden
|
-
|
7,794,177
|
-
|
7,794,177
|
Switzerland
|
-
|
33,175,196
|
-
|
33,175,196
|
|
Level 1 ($)
|
Level 2 ($)
|
Level 3 ($)
|
Total ($)
|
Taiwan
|
-
|
20,952,283
|
-
|
20,952,283
|
United Kingdom
|
25,409,012
|
61,792,148
|
-
|
87,201,160
|
United States
|
29,225,028
|
-
|
-
|
29,225,028
|
Total Common Stocks
|
139,871,988
|
775,669,942
|
0
*
|
915,541,930
|
Exchange-Traded Equity Funds
|
16,559,820
|
-
|
-
|
16,559,820
|
Money Market Funds
|
2,022,140
|
-
|
-
|
2,022,140
|
Total Investments in Securities
|
158,453,948
|
775,669,942
|
0
*
|
934,123,890
|
Investments in Derivatives
|
||||
Asset
|
||||
Forward Foreign Currency Exchange Contracts
|
-
|
2,752,623
|
-
|
2,752,623
|
Liability
|
||||
Forward Foreign Currency Exchange Contracts
|
-
|
(1,597,600
)
|
-
|
(1,597,600
)
|
Call Option Contracts Written
|
(126,058
)
|
-
|
-
|
(126,058
)
|
Total
|
158,327,890
|
776,824,965
|
0
*
|
935,152,855
|
*
|
Rounds to zero.
|
Assets
|
|
Investments in securities, at value
|
|
Unaffiliated issuers (cost $796,210,345)
|
$932,101,750
|
Affiliated issuers (cost $2,021,937)
|
2,022,140
|
Cash
|
8,274
|
Foreign currency (cost $152,221)
|
152,221
|
Cash collateral held at broker for:
|
|
Forward foreign currency exchange contracts
|
693,000
|
Unrealized appreciation on forward foreign currency exchange contracts
|
2,752,623
|
Receivable for:
|
|
Investments sold
|
2,634,285
|
Capital shares sold
|
51,736
|
Dividends
|
2,196,423
|
Foreign tax reclaims
|
1,762,574
|
Expense reimbursement due from Investment Manager
|
1,233
|
Prepaid expenses
|
9,492
|
Total assets
|
944,385,751
|
Liabilities
|
|
Option contracts written, at value (premiums received $77,840)
|
126,058
|
Unrealized depreciation on forward foreign currency exchange contracts
|
1,597,600
|
Payable for:
|
|
Investments purchased
|
152,221
|
Capital shares redeemed
|
397,743
|
Foreign capital gains taxes deferred
|
881
|
Management services fees
|
21,567
|
Distribution and/or service fees
|
334
|
Transfer agent fees
|
36,822
|
Compensation of chief compliance officer
|
78
|
Compensation of board members
|
2,040
|
Other expenses
|
79,760
|
Deferred compensation of board members
|
103,732
|
Total liabilities
|
2,518,836
|
Net assets applicable to outstanding capital stock
|
$941,866,915
|
Represented by
|
|
Paid in capital
|
851,833,529
|
Total distributable earnings (loss)
|
90,033,386
|
Total - representing net assets applicable to outstanding capital stock
|
$941,866,915
|
Class A
|
|
Net assets
|
$48,873,626
|
Shares outstanding
|
4,501,112
|
Net asset value per share
|
$10.86
|
Maximum sales charge
|
5.75%
|
Maximum offering price per share (calculated by dividing the net asset value per share by 1.0 minus the maximum sales charge for Class A shares)
|
$11.52
|
Advisor Class
|
|
Net assets
|
$185,615
|
Shares outstanding
|
17,065
|
Net asset value per share
|
$10.88
|
Institutional Class
|
|
Net assets
|
$319,359,777
|
Shares outstanding
|
29,339,790
|
Net asset value per share
|
$10.88
|
Institutional 2 Class
|
|
Net assets
|
$749,822
|
Shares outstanding
|
68,789
|
Net asset value per share
|
$10.90
|
Institutional 3 Class
|
|
Net assets
|
$572,694,660
|
Shares outstanding
|
52,510,133
|
Net asset value per share
|
$10.91
|
Class R
|
|
Net assets
|
$3,415
|
Shares outstanding
|
315
|
Net asset value per share(a)
|
$10.85
|
(a)
|
Net asset value per share rounds to this amount due to fractional shares outstanding.
|
Net investment income
|
|
Income:
|
|
Dividends - unaffiliated issuers
|
$20,630,198
|
Dividends - affiliated issuers
|
135,047
|
European Union tax reclaim
|
716,733
|
Foreign taxes withheld
|
(2,176,520
)
|
Total income
|
19,305,458
|
Expenses:
|
|
Management services fees
|
3,733,773
|
Distribution and/or service fees
|
|
Class A
|
59,152
|
Class C
|
1,528
|
Class R
|
8
|
Transfer agent fees
|
|
Class A
|
32,372
|
Advisor Class
|
128
|
Class C
|
211
|
Institutional Class
|
194,036
|
Institutional 2 Class
|
281
|
Institutional 3 Class
|
14,552
|
Class R
|
2
|
Custodian fees
|
78,805
|
Printing and postage fees
|
16,986
|
Registration fees
|
46,032
|
Accounting services fees
|
17,783
|
Legal fees
|
8,839
|
Interest on collateral
|
13,358
|
Interest on interfund lending
|
619
|
Compensation of chief compliance officer
|
78
|
Compensation of board members
|
9,630
|
Deferred compensation of board members
|
12,770
|
Other
|
20,043
|
Total expenses
|
4,260,986
|
Fees waived or expenses reimbursed by Investment Manager and its affiliates
|
(277,837
)
|
Total net expenses
|
3,983,149
|
Net investment income
|
15,322,309
|
Realized and unrealized gain (loss) - net
|
|
Net realized gain (loss) on:
|
|
Investments - unaffiliated issuers
|
28,066,710
|
Investments - affiliated issuers
|
(346
)
|
Foreign currency translations
|
(147,366
)
|
Forward foreign currency exchange contracts
|
1,773,473
|
Option contracts purchased
|
(647,186
)
|
Option contracts written
|
121,061
|
Net realized gain
|
29,166,346
|
Net change in unrealized appreciation (depreciation) on:
|
|
Investments - unaffiliated issuers
|
53,075,683
|
Investments - affiliated issuers
|
202
|
Foreign currency translations
|
84,989
|
Forward foreign currency exchange contracts
|
1,631,747
|
Option contracts written
|
(48,218
)
|
Net change in unrealized appreciation (depreciation)
|
54,744,403
|
Net realized and unrealized gain
|
83,910,749
|
Net increase in net assets resulting from operations
|
$99,233,058
|
|
Six Months Ended
August 31, 2024
(Unaudited)
|
Year Ended
February 29, 2024
|
Operations
|
||
Net investment income
|
$15,322,309
|
$18,770,153
|
Net realized gain
|
29,166,346
|
5,855,250
|
Net change in unrealized appreciation (depreciation)
|
54,744,403
|
53,604,316
|
Net increase in net assets resulting from operations
|
99,233,058
|
78,229,719
|
Distributions to shareholders
|
||
Net investment income and net realized gains
|
||
Class A
|
(394,714
)
|
(2,008,575
)
|
Advisor Class
|
(1,644
)
|
(12,830
)
|
Class C
|
-
|
(38,701
)
|
Institutional Class
|
(2,427,435
)
|
(12,861,551
)
|
Institutional 2 Class
|
(6,411
)
|
(40,549
)
|
Institutional 3 Class
|
(4,884,443
)
|
(25,657,310
)
|
Class R
|
(26
)
|
(117
)
|
Total distributions to shareholders
|
(7,714,673
)
|
(40,619,633
)
|
Decrease in net assets from capital stock activity
|
(15,489,114
)
|
(30,082,762
)
|
Total increase in net assets
|
76,029,271
|
7,527,324
|
Net assets at beginning of period
|
865,837,644
|
858,310,320
|
Net assets at end of period
|
$941,866,915
|
$865,837,644
|
|
Six Months Ended
|
Year Ended
|
||
|
August 31, 2024 (Unaudited)
|
February 29, 2024
|
||
|
Shares
|
Dollars ($)
|
Shares
|
Dollars ($)
|
Capital stock activity
|
||||
Class A
|
||||
Shares sold
|
176,595
|
1,774,911
|
257,429
|
2,488,101
|
Distributions reinvested
|
38,705
|
389,374
|
204,752
|
1,975,201
|
Shares redeemed
|
(415,825
)
|
(4,254,504
)
|
(798,190
)
|
(7,684,412
)
|
Net decrease
|
(200,525
)
|
(2,090,219
)
|
(336,009
)
|
(3,221,110
)
|
Advisor Class
|
||||
Shares sold
|
-
|
-
|
25,974
|
252,023
|
Distributions reinvested
|
144
|
1,455
|
1,232
|
11,868
|
Shares redeemed
|
(1,394
)
|
(14,773
)
|
(28,992
)
|
(278,440
)
|
Net decrease
|
(1,250
)
|
(13,318
)
|
(1,786
)
|
(14,549
)
|
Class C
|
||||
Shares sold
|
-
|
-
|
10,520
|
99,618
|
Distributions reinvested
|
-
|
-
|
3,956
|
38,020
|
Shares redeemed
|
(124,147
)
|
(1,225,588
)
|
(51,257
)
|
(491,431
)
|
Net decrease
|
(124,147
)
|
(1,225,588
)
|
(36,781
)
|
(353,793
)
|
Institutional Class
|
||||
Shares sold
|
3,259,685
|
33,746,487
|
4,271,035
|
41,419,200
|
Distributions reinvested
|
240,757
|
2,426,836
|
1,331,337
|
12,858,234
|
Shares redeemed
|
(1,555,329
)
|
(16,024,995
)
|
(8,668,211
)
|
(83,231,657
)
|
Net increase (decrease)
|
1,945,113
|
20,148,328
|
(3,065,839
)
|
(28,954,223
)
|
Institutional 2 Class
|
||||
Shares sold
|
3,098
|
30,581
|
17,340
|
167,136
|
Distributions reinvested
|
633
|
6,383
|
3,511
|
33,967
|
Shares redeemed
|
(28,569
)
|
(293,727
)
|
(17,384
)
|
(172,147
)
|
Net increase (decrease)
|
(24,838
)
|
(256,763
)
|
3,467
|
28,956
|
Institutional 3 Class
|
||||
Shares sold
|
48,524
|
492,080
|
2,465,147
|
24,218,563
|
Distributions reinvested
|
484,085
|
4,884,414
|
2,653,486
|
25,657,159
|
Shares redeemed
|
(3,598,191
)
|
(37,428,048
)
|
(4,870,801
)
|
(47,443,765
)
|
Net increase (decrease)
|
(3,065,582
)
|
(32,051,554
)
|
247,832
|
2,431,957
|
Total net decrease
|
(1,471,229
)
|
(15,489,114
)
|
(3,189,116
)
|
(30,082,762
)
|
|
Net asset value,
beginning of
period
|
Net
investment
income
(loss)
|
Net
realized
and
unrealized
gain (loss)
|
Total from
investment
operations
|
Distributions
from net
investment
income
|
Distributions
from net
realized
gains
|
Total
distributions to
shareholders
|
Class A
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$9.83
|
0.16
(c)
|
0.96
|
1.12
|
(0.09
)
|
-
|
(0.09
)
|
Year Ended 2/29/2024
|
$9.38
|
0.18
|
0.69
|
0.87
|
(0.42
)
|
-
|
(0.42
)
|
Year Ended 2/28/2023
|
$10.23
|
0.16
|
(0.88
)
|
(0.72
)
|
-
|
(0.13
)
|
(0.13
)
|
Year Ended 2/28/2022
|
$10.89
|
0.17
|
0.02
(g)
|
0.19
|
(0.27
)
|
(0.58
)
|
(0.85
)
|
Year Ended 2/28/2021
|
$8.99
|
0.06
|
2.06
|
2.12
|
(0.05
)
|
(0.17
)
|
(0.22
)
|
Year Ended 2/29/2020
|
$9.36
|
0.09
|
(0.11
)
|
(0.02
)
|
(0.31
)
|
(0.04
)
|
(0.35
)
|
Advisor Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$9.83
|
0.17
(c)
|
0.97
|
1.14
|
(0.09
)
|
-
|
(0.09
)
|
Year Ended 2/29/2024
|
$9.40
|
0.22
|
0.67
|
0.89
|
(0.46
)
|
-
|
(0.46
)
|
Year Ended 2/28/2023
|
$10.23
|
0.19
|
(0.89
)
|
(0.70
)
|
-
|
(0.13
)
|
(0.13
)
|
Year Ended 2/28/2022
|
$10.89
|
0.21
|
0.01
(g)
|
0.22
|
(0.30
)
|
(0.58
)
|
(0.88
)
|
Year Ended 2/28/2021
|
$8.99
|
0.09
|
2.05
|
2.14
|
(0.07
)
|
(0.17
)
|
(0.24
)
|
Year Ended 2/29/2020
|
$9.37
|
0.19
|
(0.19
)
|
0.00
|
(0.34
)
|
(0.04
)
|
(0.38
)
|
Institutional Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$9.84
|
0.17
(c)
|
0.96
|
1.13
|
(0.09
)
|
-
|
(0.09
)
|
Year Ended 2/29/2024
|
$9.41
|
0.21
|
0.68
|
0.89
|
(0.46
)
|
-
|
(0.46
)
|
Year Ended 2/28/2023
|
$10.24
|
0.19
|
(0.89
)
|
(0.70
)
|
-
|
(0.13
)
|
(0.13
)
|
Year Ended 2/28/2022
|
$10.89
|
0.19
|
0.04
(g)
|
0.23
|
(0.30
)
|
(0.58
)
|
(0.88
)
|
Year Ended 2/28/2021
|
$9.00
|
0.13
|
2.00
|
2.13
|
(0.07
)
|
(0.17
)
|
(0.24
)
|
Year Ended 2/29/2020
|
$9.37
|
0.19
|
(0.18
)
|
0.01
|
(0.34
)
|
(0.04
)
|
(0.38
)
|
Institutional 2 Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$9.85
|
0.18
(c)
|
0.96
|
1.14
|
(0.09
)
|
-
|
(0.09
)
|
Year Ended 2/29/2024
|
$9.43
|
0.21
|
0.68
|
0.89
|
(0.47
)
|
-
|
(0.47
)
|
Year Ended 2/28/2023
|
$10.25
|
0.16
|
(0.85
)
|
(0.69
)
|
-
|
(0.13
)
|
(0.13
)
|
Year Ended 2/28/2022
|
$10.90
|
0.20
|
0.04
(g)
|
0.24
|
(0.31
)
|
(0.58
)
|
(0.89
)
|
Year Ended 2/28/2021
|
$9.00
|
0.10
|
2.05
|
2.15
|
(0.08
)
|
(0.17
)
|
(0.25
)
|
Year Ended 2/29/2020
|
$9.38
|
0.19
|
(0.18
)
|
0.01
|
(0.35
)
|
(0.04
)
|
(0.39
)
|
|
Net
asset
value,
end of
period
|
Total
return
|
Total gross
expense
ratio to
average
net assets(a)
|
Total net
expense
ratio to
average
net assets(a),(b)
|
Net investment
income (loss)
ratio to
average
net assets
|
Portfolio
turnover
|
Net
assets,
end of
period
(000's)
|
Class A
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$10.86
|
11.42%
|
1.27%
(d),(e)
|
1.21%
(d),(e)
|
3.12%
(c)
|
23%
|
$48,874
|
Year Ended 2/29/2024
|
$9.83
|
9.36%
|
1.30%
(d),(e)
|
1.22%
(d),(e),(f)
|
1.90%
|
42%
|
$46,194
|
Year Ended 2/28/2023
|
$9.38
|
(6.89%
)
|
1.28%
(d),(e)
|
1.22%
(d),(e),(f)
|
1.74%
|
60%
|
$47,250
|
Year Ended 2/28/2022
|
$10.23
|
1.38%
|
1.27%
(d),(e)
|
1.22%
(d),(e),(f)
|
1.47%
|
43%
|
$55,723
|
Year Ended 2/28/2021
|
$10.89
|
23.80%
|
1.33%
(d),(e)
|
1.24%
(d),(e),(f)
|
0.59%
|
39%
|
$57,243
|
Year Ended 2/29/2020
|
$8.99
|
(0.46%
)
|
1.40%
|
1.26%
|
0.94%
|
48%
|
$431
|
Advisor Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$10.88
|
11.67%
|
1.03%
(d),(e)
|
0.96%
(d),(e)
|
3.35%
(c)
|
23%
|
$186
|
Year Ended 2/29/2024
|
$9.83
|
9.59%
|
1.05%
(d),(e)
|
0.97%
(d),(e),(f)
|
2.26%
|
42%
|
$180
|
Year Ended 2/28/2023
|
$9.40
|
(6.69%
)
|
1.03%
(d),(e)
|
0.97%
(d),(e),(f)
|
2.05%
|
60%
|
$189
|
Year Ended 2/28/2022
|
$10.23
|
1.64%
|
1.02%
(d),(e)
|
0.97%
(d),(e),(f)
|
1.83%
|
43%
|
$262
|
Year Ended 2/28/2021
|
$10.89
|
24.07%
|
1.08%
(d),(e)
|
0.99%
(d),(e),(f)
|
0.91%
|
39%
|
$368
|
Year Ended 2/29/2020
|
$8.99
|
(0.30%
)
|
1.15%
|
1.01%
|
1.98%
|
48%
|
$19
|
Institutional Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$10.88
|
11.55%
|
1.03%
(d),(e)
|
0.96%
(d),(e)
|
3.37%
(c)
|
23%
|
$319,360
|
Year Ended 2/29/2024
|
$9.84
|
9.59%
|
1.05%
(d),(e)
|
0.97%
(d),(e),(f)
|
2.14%
|
42%
|
$269,598
|
Year Ended 2/28/2023
|
$9.41
|
(6.68%
)
|
1.03%
(d),(e)
|
0.97%
(d),(e),(f)
|
2.05%
|
60%
|
$286,669
|
Year Ended 2/28/2022
|
$10.24
|
1.73%
|
1.02%
(d),(e)
|
0.97%
(d),(e),(f)
|
1.68%
|
43%
|
$275,013
|
Year Ended 2/28/2021
|
$10.89
|
23.93%
|
1.10%
(d),(e)
|
1.00%
(d),(e),(f)
|
1.40%
|
39%
|
$215,765
|
Year Ended 2/29/2020
|
$9.00
|
(0.19%
)
|
1.15%
|
1.02%
|
1.98%
|
48%
|
$131,881
|
Institutional 2 Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$10.90
|
11.66%
|
0.96%
(d),(e)
|
0.90%
(d),(e)
|
3.52%
(c)
|
23%
|
$750
|
Year Ended 2/29/2024
|
$9.85
|
9.59%
|
0.98%
(d),(e)
|
0.90%
(d),(e)
|
2.16%
|
42%
|
$923
|
Year Ended 2/28/2023
|
$9.43
|
(6.58%
)
|
0.97%
(d),(e)
|
0.90%
(d),(e)
|
1.78%
|
60%
|
$850
|
Year Ended 2/28/2022
|
$10.25
|
1.81%
|
0.95%
(d),(e)
|
0.90%
(d),(e)
|
1.77%
|
43%
|
$454
|
Year Ended 2/28/2021
|
$10.90
|
24.16%
|
0.99%
(d),(e)
|
0.90%
(d),(e)
|
1.02%
|
39%
|
$439
|
Year Ended 2/29/2020
|
$9.00
|
(0.18%
)
|
1.04%
|
0.91%
|
1.99%
|
48%
|
$47
|
|
Net asset value,
beginning of
period
|
Net
investment
income
(loss)
|
Net
realized
and
unrealized
gain (loss)
|
Total from
investment
operations
|
Distributions
from net
investment
income
|
Distributions
from net
realized
gains
|
Total
distributions to
shareholders
|
Institutional 3 Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$9.86
|
0.18
(c)
|
0.96
|
1.14
|
(0.09
)
|
-
|
(0.09
)
|
Year Ended 2/29/2024
|
$9.43
|
0.22
|
0.69
|
0.91
|
(0.48
)
|
-
|
(0.48
)
|
Year Ended 2/28/2023
|
$10.25
|
0.19
|
(0.88
)
|
(0.69
)
|
-
|
(0.13
)
|
(0.13
)
|
Year Ended 2/28/2022
|
$10.91
|
0.21
|
0.03
(g)
|
0.24
|
(0.32
)
|
(0.58
)
|
(0.90
)
|
Year Ended 2/28/2021
|
$9.00
|
0.12
|
2.05
|
2.17
|
(0.09
)
|
(0.17
)
|
(0.26
)
|
Year Ended 2/29/2020
|
$9.38
|
0.21
|
(0.19
)
|
0.02
|
(0.36
)
|
(0.04
)
|
(0.40
)
|
Class R
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$9.82
|
0.15
(c)
|
0.96
|
1.11
|
(0.08
)
|
-
|
(0.08
)
|
Year Ended 2/29/2024
|
$9.36
|
0.16
|
0.67
|
0.83
|
(0.37
)
|
-
|
(0.37
)
|
Year Ended 2/28/2023
|
$10.23
|
0.13
|
(0.87
)
|
(0.74
)
|
-
|
(0.13
)
|
(0.13
)
|
Year Ended 2/28/2022
|
$10.88
|
0.15
|
0.02
(g)
|
0.17
|
(0.24
)
|
(0.58
)
|
(0.82
)
|
Year Ended 2/28/2021
|
$8.99
|
0.20
|
1.88
|
2.08
|
(0.02
)
|
(0.17
)
|
(0.19
)
|
Year Ended 2/29/2020
|
$9.36
|
0.18
|
(0.22
)
|
(0.04
)
|
(0.29
)
|
(0.04
)
|
(0.33
)
|
Notes to Financial Highlights
|
|
(a)
|
In addition to the fees and expenses that the Fund bears directly, the Fund indirectly bears a pro rata share of the fees and expenses of any other funds in which it invests. Such indirect expenses are not included in the Fund's reported expense ratios.
|
(b)
|
Total net expenses include the impact of certain fee waivers/expense reimbursements made by the Investment Manager and certain of its affiliates, if applicable.
|
(c)
|
Includes income resulting from European Union tax reclaims. The effect of these amounted to:
|
Class
|
Net Investment income per share
|
Net Investment income ratio
|
Six Months Ended 8/31/2024 (Unaudited)
|
||
Class A
|
$0.01
|
0.16%
|
Advisor Class
|
$0.01
|
0.16%
|
Institutional Class
|
$0.01
|
0.16%
|
Institutional 2 Class
|
$0.01
|
0.16%
|
Institutional 3 Class
|
$0.01
|
0.16%
|
Class R
|
$0.01
|
0.16%
|
(d)
|
Ratios include interest on collateral expense which is less than 0.01%.
|
(e)
|
Ratios include interfund lending expense which is less than 0.01%.
|
(f)
|
The benefits derived from expense reductions had an impact of less than 0.01%.
|
(g)
|
Calculation of the net gain (loss) per share (both realized and unrealized) does not correlate to the aggregate realized and unrealized gain (loss) presented in the Statement of Operations due to timing of Fund shares sold and redeemed in relation to fluctuations in the market value of the portfolio.
|
|
Net
asset
value,
end of
period
|
Total
return
|
Total gross
expense
ratio to
average
net assets(a)
|
Total net
expense
ratio to
average
net assets(a),(b)
|
Net investment
income (loss)
ratio to
average
net assets
|
Portfolio
turnover
|
Net
assets,
end of
period
(000's)
|
Institutional 3 Class
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$10.91
|
11.66%
|
0.89%
(d),(e)
|
0.83%
(d),(e)
|
3.50%
(c)
|
23%
|
$572,695
|
Year Ended 2/29/2024
|
$9.86
|
9.81%
|
0.92%
(d),(e)
|
0.84%
(d),(e)
|
2.27%
|
42%
|
$547,726
|
Year Ended 2/28/2023
|
$9.43
|
(6.58%
)
|
0.90%
(d),(e)
|
0.85%
(d),(e)
|
2.13%
|
60%
|
$521,856
|
Year Ended 2/28/2022
|
$10.25
|
1.78%
|
0.89%
(d),(e)
|
0.84%
(d),(e)
|
1.85%
|
43%
|
$666,445
|
Year Ended 2/28/2021
|
$10.91
|
24.34%
|
0.94%
(d),(e)
|
0.84%
(d),(e)
|
1.21%
|
39%
|
$555,487
|
Year Ended 2/29/2020
|
$9.00
|
(0.11%
)
|
0.97%
|
0.85%
|
2.18%
|
48%
|
$119,513
|
Class R
|
|||||||
Six Months Ended 8/31/2024 (Unaudited)
|
$10.85
|
11.39%
|
1.52%
(d),(e)
|
1.46%
(d),(e)
|
2.85%
(c)
|
23%
|
$3
|
Year Ended 2/29/2024
|
$9.82
|
9.01%
|
1.55%
(d),(e)
|
1.47%
(d),(e),(f)
|
1.62%
|
42%
|
$3
|
Year Ended 2/28/2023
|
$9.36
|
(7.09%
)
|
1.50%
(d),(e)
|
1.47%
(d),(e),(f)
|
1.46%
|
60%
|
$3
|
Year Ended 2/28/2022
|
$10.23
|
1.18%
|
1.51%
(d),(e)
|
1.47%
(d),(e),(f)
|
1.24%
|
43%
|
$3
|
Year Ended 2/28/2021
|
$10.88
|
23.43%
|
1.59%
(d),(e)
|
1.48%
(d),(e),(f)
|
2.33%
|
39%
|
$3
|
Year Ended 2/29/2020
|
$8.99
|
(0.73%
)
|
1.65%
|
1.52%
|
1.88%
|
48%
|
$19
|
|
Asset derivatives
|
|
Risk exposure
category
|
Statement
of assets and liabilities
location
|
Fair value ($)
|
Foreign exchange risk
|
Unrealized appreciation on forward foreign currency exchange contracts
|
2,752,623
|
|
Liability derivatives
|
|
Risk exposure
category
|
Statement
of assets and liabilities
location
|
Fair value ($)
|
Equity risk
|
Option contracts written, at value
|
126,058
|
Foreign exchange risk
|
Unrealized depreciation on forward foreign currency exchange contracts
|
1,597,600
|
Total
|
|
1,723,658
|
Amount of realized gain (loss) on derivatives recognized in income
|
||||
Risk exposure category
|
Forward
foreign
currency
exchange
contracts
($)
|
Option
contracts
purchased
($)
|
Option
contracts
written
($)
|
Total
($)
|
Equity risk
|
-
|
(647,186
)
|
121,061
|
(526,125
)
|
Foreign exchange risk
|
1,773,473
|
-
|
-
|
1,773,473
|
Total
|
1,773,473
|
(647,186
)
|
121,061
|
1,247,348
|
Change in unrealized appreciation (depreciation) on derivatives recognized in income
|
|||
Risk exposure category
|
Forward
foreign
currency
exchange
contracts
($)
|
Option
contracts
written
($)
|
Total
($)
|
Equity risk
|
-
|
(48,218
)
|
(48,218
)
|
Foreign exchange risk
|
1,631,747
|
-
|
1,631,747
|
Total
|
1,631,747
|
(48,218
)
|
1,583,529
|
Derivative instrument
|
Average
value ($)
|
Option contracts purchased
|
58,430
|
Option contracts written
|
(13,487
)
|
Derivative instrument
|
Average unrealized
appreciation ($)
|
Average unrealized
depreciation ($)
|
Forward foreign currency exchange contracts
|
3,111,072
|
(2,542,565
)
|
|
Barclays
($)
|
Citi
($)
|
Goldman
Sachs
International
($)
|
HSBC
($)
|
JPMorgan
($)
|
Morgan
Stanley
($) (a)
|
Morgan
Stanley
($) (a)
|
State
Street
($)
|
UBS
($)
|
Wells
Fargo
($)
|
Total
($)
|
Assets
|
|||||||||||
Forward foreign currency exchange
contracts
|
23,350
|
785,035
|
592,123
|
328,536
|
5,450
|
59,534
|
-
|
114,142
|
108,469
|
735,984
|
2,752,623
|
Liabilities
|
|||||||||||
Forward foreign currency exchange
contracts
|
587,468
|
-
|
-
|
314,963
|
27,346
|
667,823
|
-
|
-
|
-
|
-
|
1,597,600
|
Call option contracts written
|
-
|
-
|
-
|
-
|
-
|
126,058
|
-
|
-
|
-
|
126,058
|
|
Total liabilities
|
587,468
|
-
|
-
|
314,963
|
27,346
|
667,823
|
126,058
|
-
|
-
|
-
|
1,723,658
|
Total financial and derivative net
assets
|
(564,118
)
|
785,035
|
592,123
|
13,573
|
(21,896
)
|
(608,289
)
|
(126,058
)
|
114,142
|
108,469
|
735,984
|
1,028,965
|
Total collateral received (pledged) (b)
|
-
|
-
|
-
|
-
|
-
|
(608,289
)
|
(126,058
)
|
-
|
-
|
-
|
(734,347
)
|
Net amount (c)
|
(564,118
)
|
785,035
|
592,123
|
13,573
|
(21,896
)
|
-
|
-
|
114,142
|
108,469
|
735,984
|
1,763,312
|
(a)
|
Exposure can only be netted across transactions governed under the same master agreement with the same legal entity.
|
(b)
|
In some instances, the actual collateral received and/or pledged may be more than the amount shown due to overcollateralization.
|
(c)
|
Represents the net amount due from/(to) counterparties in the event of default.
|
|
Effective rate (%)
|
Class A
|
0.14
|
Advisor Class
|
0.14
|
Class C
|
0.02
(a)
|
Institutional Class
|
0.14
|
Institutional 2 Class
|
0.07
|
Institutional 3 Class
|
0.01
|
Class R
|
0.14
|
(a)
|
Unannualized.
|
|
Front End (%)
|
CDSC (%)
|
Amount ($)
|
Class A
|
5.75
|
0.50 - 1.00
(a)
|
4,531
|
Class C
|
-
|
1.00
(b)
|
-
|
(a)
|
This charge is imposed on certain investments of between $1 million and $50 million redeemed within 18 months after purchase, as follows: 1.00% if redeemed within 12 months after purchase, and 0.50% if redeemed more than 12, but less than 18, months after purchase, with certain limited exceptions.
|
(b)
|
This charge applies to redemptions within 12 months after purchase, with certain limited exceptions.
|
|
July 1, 2024
through
June 30, 2025 (%)
|
Prior to
July 1, 2024 (%)
|
Class A
|
1.22
|
1.22
|
Advisor Class
|
0.97
|
0.97
|
Institutional Class
|
0.97
|
0.97
|
Institutional 2 Class
|
0.90
|
0.89
|
Institutional 3 Class
|
0.84
|
0.83
|
Class R
|
1.47
|
1.47
|
Federal
tax cost ($)
|
Gross unrealized
appreciation ($)
|
Gross unrealized
(depreciation) ($)
|
Net unrealized
appreciation ($)
|
798,154,000
|
194,618,000
|
(57,619,000
)
|
136,999,000
|
No expiration
short-term ($)
|
No expiration
long-term ($)
|
Total ($)
|
(35,659,500
)
|
(35,784,082
)
|
(71,443,582
)
|
Borrower or lender
|
Average loan
balance ($)
|
Weighted average
interest rate (%)
|
Number of days
with outstanding loans
|
Borrower
|
1,266,667
|
5.87
|
3
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-End Management Investment Companies.
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.
Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies is included in Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
Statement regarding basis for approval of Investment Advisory Contract is included in Item 7 of this Form N-CSR.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There were no material changes to the procedures by which shareholders may recommend nominees to the registrant's board of directors implemented since the registrant last provided disclosure as to such procedures in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K or Item 15 of Form N-CSR.
Item 16. Controls and Procedures.
(a) The registrant's principal executive officer and principal financial officer, based on their evaluation of the registrant's disclosure controls and procedures as of a date within 90 days of the filing of this report, have concluded that such controls and procedures are adequately designed to ensure that information required to be disclosed by the registrant in Form N-CSR is accumulated and communicated to the registrant's management, including the principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
(b) There was no change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
(a)(1) Not applicable.
(a)(2) Certifications pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) attached hereto as Exhibit 99.CERT.
(b) Certification pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (17 CFR 270.30a-2(b)) attached hereto as Exhibit 99.906CERT.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(registrant) | Columbia Funds Series Trust II |
|
|
By (Signature and Title) | /s/ Daniel J. Beckman |
Daniel J. Beckman, President and Principal Executive Officer | |
|
|
Date | October 23, 2024 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title) | /s/ Daniel J. Beckman |
Daniel J. Beckman, President and Principal Executive Officer | |
|
|
Date | October 23, 2024 |
|
|
By (Signature and Title) | /s/ Michael G. Clarke |
Michael G. Clarke, Chief Financial Officer, | |
Principal Financial Officer and Senior Vice President | |
|
|
Date | October 23, 2024 |
|
|
By (Signature and Title) | /s/ Charles H. Chiesa |
Charles H. Chiesa, Treasurer, Chief Accounting | |
Officer and Principal Financial Officer | |
|
|
Date | October 23, 2024 |